ONE-WAYOngoing theme · still written in the latest filings

Expanding revenue from core products and strengthening the product portfolio

An ongoing focus on growing revenue and strengthening the product portfolio by expanding sales and launching products in key areas such as liquid formulations, easy-to-use injectors, biosimilars and next-generation drugs.

Companies5How many companies write about this.

Threads7One company can carry more than one thread here.

PeriodFY2016 →Still being written about.

Directionhelps7 helps · 0 hurts · 0 flat